Yahoo! Finance Search - Finance Home - Yahoo! - Help

Friday, May 24 2013 2:52am ET - U.S. Markets open in 6 hours and 38 minutes.
Industry Center - Drug Delivery
Industry Center > Drug Delivery > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Delivery News
Latest News
Thursday, May 23, 2013
·Elan Board Rejects Royalty Pharma's Latest Offer
at Motley Fool - Thu 11:14 pm ET
·Reading the fine print turns initial Alkermes share loss into a gain
at MarketWatch - Thu 7:06 pm ET
·Elan Announces Pricing of US$850 Million in Aggregate Principal Amount of Senior Notes Due 2021
Business Wire - Thu 4:27 pm ET
·Alkermes’ Corporate Presentation to be Webcast at the Deutsche Bank 38th Annual dbAccess Health Care Conference
Business Wire - Thu 4:00 pm ET
·Alkermes' CEO Discusses F4Q13 Results - Earnings Call Transcript
- Thu 1:20 pm ET
·Elan board rejects Royalty Pharma's revised tender offer
- Thu 11:41 am ET
·Elan Corporation, plc’s Board of Directors Unanimously Reject Royalty Pharma’s Revised Tender Offer
Business Wire - Thu 11:40 am ET
·Alkermes Earnings: Everything You Must Know Now
- Thu 8:46 am ET
·pSivida Corp President and CEO, Dr. Paul Ashton Publishes New Blog Entitled ''Big and Small Picture''
- Thu 8:30 am ET
·Flamel Technologies Obtains Rights to Two Molecules of Trigger Lock Product Line
Marketwire - Thu 7:30 am ET
·Alkermes plc Reports Financial Results for Fiscal Year 2013 and Provides Financial Expectations
Business Wire - Thu 7:00 am ET
·Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
PR Newswire - Thu 6:31 am ET
Wednesday, May 22, 2013
·Alkermes Earnings Seen Rising, But Sales Uncertain
at Investor's Business Daily, Inc. - Wed 3:54 pm ET
·Moody's to review Hospira rating for downgrade
AP - Wed 3:11 pm ET
·Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine
PR Newswire - Wed 9:00 am ET
·Alkermes Announces Data on ALKS 5461 and ALKS 3831 to Be Presented at 53rd Annual NCDEU Meeting
Business Wire - Wed 7:00 am ET
Tuesday, May 21, 2013
·A first in Quebec: Valeant officially inaugurates its international headquarters in Laval
CNW Group - Tue May 21
·When Savvy Dealmaking Borders on Reckless Spending
at Motley Fool - Tue May 21
·Valeant Pharmaceuticals Announces 2013 Annual Meeting Results
CNW Group - Tue May 21
·Valeant Pharmaceuticals Announces 2013 Annual Meeting Results
PR Newswire - Tue May 21
More Latest News...
Sponsor Results
*Get Debt Free in 2013
BBB A+ Rated Debt Services Leader. * As Featured in CNN, PBS & Forbes
www.ConsolidatedCredit.org
personal loan
Receive up to $50,000 in Grants.No Credit Checks,No Cosigners Needed.
www.GovernmentGrantUSA.Org
Need Help with Debt?
Who is Reliable? Who Can Help? Free Reports on Best Debt Relief Firms
DebtReliefCompanies.net
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo! Page
( About My Yahoo! and RSS )

Drug Delivery Headlines
More Finance RSS Feeds


Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2013 Morningstar, Inc. All Rights Reserved. Company information © 2013 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2013, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.

Questions or Comments?